Cytodyn Inc (CYDY)

[docj]

News Desk - Wall Street Reporter ([e-mail])
To:you Details



January 3, 2020
IT'S OFFICIAL: CytoDyn, Inc. (OTC: CYDY) has increased +247% since presenting at Wall Street Reporter's Next Super Stock conference November 14, 2019. CYDY stock has achieved escape velocity - and surging on positive news and price momentum.

SAVE THE DATE:January 15, 2020, CytoDyn CEO, Nader Pourhassan, Ph.D., will be doing a follow-up presentation. Click here to join the livestream, and participate in Q&A and gain first-hand knowledge of the company's next big developments...





On December 17, 2019 CYDY announced major milestone news - an $87.5 million licensing deal for commercializing Leronlimab to treat HIV.
CYDY is now officially entering "SUPER STOCK" territory with it's stock price break-out and potential for even bigger upside in the months ahead...

Check out CYDY's November 14, 2019 NEXT SUPER STOCK conference presentation.


WINNERS like CYDY - is exactly what Wall Street Reporter's NEXT SUPER STOCK conference is all about - we showcase stocks which have 10X upside potential.

SAVE THE DATE: January 15, 2020
Wall Street Reporter's NEXT SUPER STOCK Live!
CYDY will again be a featured presenter at this livestream event, and discussing what's ahead for 2020!
CLICK HERE TO REGISTER NOW (free)


In case you missed, CYDY's NEXT SUPER STOCK livestream, click here for the full conference video replay.

As you can see by these results, there is a good reason THOUSANDS of institutional and savvy individual investors participate and follow the NEXT SUPER STOCK conference presentations.